BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15136665)

  • 1. Where has all the white matter gone? Unraveling the mysteries of leukoencephalopathies.
    Kaye EM; Moser H
    Neurology; 2004 May; 62(9):1464-5. PubMed ID: 15136665
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on genetic disorders affecting white matter.
    Kaye EM
    Pediatr Neurol; 2001 Jan; 24(1):11-24. PubMed ID: 11182276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of mutations for the diagnosis of vanishing white matter disease.
    Scali O; Di Perri C; Federico A
    Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on white matter genetic disorders.
    Messing A; Brenner M; Johnson AB; Goldman JE
    Pediatr Neurol; 2001 Oct; 25(4):347-8; author reply 348. PubMed ID: 11704412
    [No Abstract]   [Full Text] [Related]  

  • 5. Conversion of a normal MRI into an MRI showing a cystic leukoencephalopathy is not a known feature of vanishing white matter.
    van der Knaap MS; Schiffmann R; Scheper GC
    Neuropediatrics; 2007 Oct; 38(5):264. PubMed ID: 18330844
    [No Abstract]   [Full Text] [Related]  

  • 6. Vanishing white matter disease: the first reported chinese patient.
    Wong SS; Luk DC; Wong VC; Scheper GC; van der Knaap MS
    J Child Neurol; 2008 Jun; 23(6):710-4. PubMed ID: 18539998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ovarioleukodystrophy.
    Mathis S; Scheper GC; Baumann N; Petit E; Gil R; van der Knaap MS; Neau JP
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1035-7. PubMed ID: 18678442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arg113His mutation in eIF2Bepsilon as cause of leukoencephalopathy in adults.
    van der Knaap MS; Leegwater PA; van Berkel CG; Brenner C; Storey E; Di Rocco M; Salvi F; Pronk JC
    Neurology; 2004 May; 62(9):1598-600. PubMed ID: 15136689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukoencephalopathy with vanishing white matter:: an adult onset case.
    Biancheri R; Rossi A; Di Rocco M; Filocamo M; Pronk JC; van der Knaap MS; Tortori-Donati P
    Neurology; 2003 Dec; 61(12):1818-9. PubMed ID: 14694060
    [No Abstract]   [Full Text] [Related]  

  • 10. Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up.
    Bektaş G; Yeşil G; Özkan MU; Yıldız EP; Uzunhan TA; Çalışkan M
    Clin Neurol Neurosurg; 2018 Aug; 171():190-193. PubMed ID: 29933199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter.
    Geva M; Cabilly Y; Assaf Y; Mindroul N; Marom L; Raini G; Pinchasi D; Elroy-Stein O
    Brain; 2010 Aug; 133(Pt 8):2448-61. PubMed ID: 20826436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation. First Polish cases.
    Mierzewska H; van der Knaap MS; Scheper GC; Jurkiewicz E; Schmidt-Sidor B; Szymańska K
    Folia Neuropathol; 2006; 44(2):144-8. PubMed ID: 16823698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive megalencephaly due to specific EIF2Bepsilon mutations in two unrelated families.
    Passemard S; Gelot A; Fogli A; N'Guyen S; Barnerias C; Niel F; Doummar D; Arbues AS; Mignot C; de Villemeur TB; Ponsot G; Boespflug-Tanguy O; Rodriguez D
    Neurology; 2007 Jul; 69(4):400-2. PubMed ID: 17646634
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of genotype on the natural history of eIF2B-related leukodystrophies.
    Fogli A; Schiffmann R; Bertini E; Ughetto S; Combes P; Eymard-Pierre E; Kaneski CR; Pineda M; Troncoso M; Uziel G; Surtees R; Pugin D; Chaunu MP; Rodriguez D; Boespflug-Tanguy O
    Neurology; 2004 May; 62(9):1509-17. PubMed ID: 15136673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing "undiagnosed" leukodystrophies: The role of molecular genetics.
    Noetzel MJ
    Neurology; 2004 Mar; 62(6):847-8. PubMed ID: 15037679
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic and clinical heterogeneity in eIF2B-related disorder.
    Maletkovic J; Schiffmann R; Gorospe JR; Gordon ES; Mintz M; Hoffman EP; Alper G; Lynch DR; Singhal BS; Harding C; Amartino H; Brown CM; Chan A; Renaud D; Geraghty M; Jensen L; Senbil N; Kadom N; Nazarian J; Yuanjian Feng ; Zuyi Wang ; Hartka T; Morizono H; Vanderver A
    J Child Neurol; 2008 Feb; 23(2):205-15. PubMed ID: 18263758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological picture. Tigroid and leopard skin pattern of dysmyelination in metachromatic leucodystrophy.
    Nandhagopal R; Krishnamoorthy SG
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):344. PubMed ID: 16484641
    [No Abstract]   [Full Text] [Related]  

  • 18. [Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases].
    Carra-Dalliere C; Horzinski L; Ayrignac X; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Seze J; Sedel F; Guennoc AM; Sartori E; Laplaud D; Antoine JC; Fogli A; Boespflug-Tanguy O; Labauge P
    Rev Neurol (Paris); 2011 Nov; 167(11):802-11. PubMed ID: 21676421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukodystrophies and other genetic metabolic leukoencephalopathies in children and adults.
    Kohlschütter A; Bley A; Brockmann K; Gärtner J; Krägeloh-Mann I; Rolfs A; Schöls L
    Brain Dev; 2010 Feb; 32(2):82-9. PubMed ID: 19427149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant form of vanishing white matter-like leukoencephalopathy.
    Labauge P; Fogli A; Castelnovo G; Le Bayon A; Horzinski L; Nicoli F; Cozzone P; Pagès M; Briere C; Marty-Double C; Delhaume O; Gelot A; Boespflug-Tanguy O; Rodriguez D
    Ann Neurol; 2005 Oct; 58(4):634-9. PubMed ID: 16047349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.